AbilityPharma closes €7 million round for metastatic pancreatic cancer drug ABTL0812
AbilityPharma closes €7 million round to fully fund its international Phase 2b clinical trial with the antitumor drug ABTL0812 in pancreatic cancer patients.
Stay updated with breaking news from Strategic Lines. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
AbilityPharma closes €7 million round to fully fund its international Phase 2b clinical trial with the antitumor drug ABTL0812 in pancreatic cancer patients.
New-generation batteries are about to see the light thanks to the project being carried out by the company Napptilus Battery Labs (NBL) in collaboration with the Catalan Institute of Nanotechnology and Nanoscience (ICN2) at the Autonomous University of Barcelona, ??which has accreditation from the Spanish government as a Severo Ochoa Center of Excellence, for research and development of new energy storage technologies.
The recent bill (Disegno Di Legge, DDL) amending the Italian Industrial Property Code (IPC), approved by the Council of Ministers on 6 April 2022…